CT45A1‐expressing MSI‐H CRC cells, but not MSS CRC cells, exhibited enhanced resistance to NK cell cytotoxicity and generated homotypic cell‐in‐cell (CIC) structures with CT45A1‐expressing outer cells, protecting the inner cancer cells against therapeutic targeting. This evidence concerns the gene CT45A1 and cancer.